汉族特应性皮炎患者Th22细胞高表达ICOS及其与疾病活动度的关联
该研究在汉族特应性皮炎(AD)患者中检测ICOS/ICOSL表达,发现患者表达ICOS的Th22细胞及表达ICOSL的B细胞和单核细胞均高于健康对照;ICOSL可促进AD外周血单个核细胞增殖及CCR4、CCR10、IL-22表达,并增强对角质形成细胞丝聚蛋白的下调;ICOS+ Th22细胞和ICOSL+ B细胞与SCORAD评分及总IgE水平相关。
要点
- 汉族AD患者循环Th22细胞、血清IL-22及皮损IL-22+细胞均显著增高。
- ICOSL刺激增加AD PBMCs增殖及CCR4、CCR10、IL-22表达。
- ICOS+ Th22细胞和ICOSL+ B细胞与疾病活动度及总IgE相关。
核心结论
- ICOS/ICOSL表达及其效应与汉族AD的Th22偏移和发病机制相关,提示ICOSL、ICOS、Th22细胞及IL-22是潜在治疗靶点。
研究设计与样本
- 研究比较汉族AD患者与健康对照的ICOS和ICOSL表达,并评估ICOSL刺激对AD PBMCs增殖及Th22趋化因子产生的影响。
- 研究探索表达ICOS的Th22细胞与患者疾病活动度及IgE水平的关联。
主要发现
- AD患者表达ICOS的Th22细胞以及表达ICOSL的CD19+ B细胞和CD14+单核细胞水平均高于健康对照。
- ICOSL增加AD PBMCs的增殖及CCR4、CCR10和IL-22的表达。
- ICOSL处理显著增强与AD患者PBMCs共培养的角质形成细胞中丝聚蛋白表达的下调。
- AD队列中ICOS+ Th22细胞和ICOSL+ B细胞血液水平与SCORAD评估的疾病活动度及总IgE水平相关。
- 汉族AD患者循环Th22细胞、血清IL-22水平及皮损中IL-22+细胞均明显增高。
临床怎么用
- ICOS+ Th22细胞和ICOSL+ B细胞可作为汉族AD患者疾病活动的潜在临床生物标志物。
- 靶向ICOS和ICOSL的治疗策略可能使汉族AD患者获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic dermatitis (AD) is a heterogeneous disease, characterized by excess T helper (Th) 22 activation in Asian AD. Inducible T-cell costimulator (ICOS) is crucial for T-cell activation and differentiation. However, the role of ICOS in AD and its effect on Th22 cells remain unclear. OBJECTIVES: To gain a better understanding of the role of ICOS and ICOS ligand (ICOSL) in the pathogenesis of Asian AD and its underlying mechanisms. METHODS: We quantified ICOS and ICOSL expression in Han Chinese patients with AD and healthy controls (HC). Then, we assessed the proliferation and the production of the Th22 chemokines CCR4 and CCR10 by ICOSL-stimulated AD peripheral blood mononuclear cells (PBMCs) as well as their effects on keratinocyte filaggrin production. Finally, we explored the link between ICOS-expressing Th22 cells and disease activity and IgE levels in our patients with AD. RESULTS: Our patients with AD showed higher levels of ICOS-expressing Th22 cells as well as ICOSL-expressing CD19+ B cells and CD14+ monocytes compared with HC. ICOSL increased the proliferation and expression of CCR4 and CCR10, and of interleukin (IL)-22 in AD PBMCs. ICOSL treatment also significantly increased the downregulation of filaggrin expression by keratinocytes cocultured with PBMCs from patients with AD. Finally, blood levels of ICOS+ Th22 cells and ICOSL+ B cells in this AD cohort were correlated with disease activity as assessed by the SCORing Atopic Dermatitis index and with total IgE levels. In Han Chinese patients with AD, circulating Th22 cells, serum levels of IL-22 and IL-22+ cells in lesional skin were all markedly increased. CONCLUSIONS: Our findings demonstrate that ICOS/ICOSL expression and effects are linked to Th22 skewing and the pathogenesis of Han Chinese AD, which suggests ICOSL and ICOS as well as Th22 cells and IL-22 as new and promising therapeutic targets. What's already known about this topic? In Asian patients, atopic dermatitis (AD) is characterized by excess T helper (Th) 22 activation. Inducible T-cell costimulator (ICOS) is crucial for T-cell activation and differentiation. What does this study add? This study demonstrates that circulating Th22 cells, serum levels of interleukin (IL)-22 and IL-22+ cells are all markedly increased in lesional skin in Han Chinese patients with AD. In Han Chinese patients with AD, ICOS and ICOS ligand (ICOSL) drive Th22 skewing and increase filaggrin downregulation, and ICOS+ Th22 cells and ICOSL+ B cells are linked to disease activity. What is the translational message? ICOS+ Th22 cells and ICOSL+ B cells are potential clinical biomarkers of disease activity in Han Chinese patients with AD. ICOS- and ICOSL-targeted treatment approaches may benefit Han Chinese patients with AD.
引用
- Jiao Q, Qian Q, Liu C, et al. T helper 22 cells from Han Chinese patients with atopic dermatitis exhibit high expression of inducible T-cell costimulator. Br J Dermatol. 2019. PMID: 31090221. doi:10.1111/bjd.18040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。